• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染作为肝细胞癌的一个危险因素:埃塞俄比亚的一项病例对照研究。

Helicobacter pylori Infection as a Risk Factor for Hepatocellular Carcinoma: A Case-Control Study in Ethiopia.

作者信息

Mekonnen Hailemichael Desalegn, Fisseha Henok, Getinet Tewodros, Tekle Fisseha, Galle Peter R

机构信息

Medical Department, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Myungsung Christian Medical Center, Addis Ababa, Ethiopia.

出版信息

Int J Hepatol. 2018 Dec 2;2018:1941728. doi: 10.1155/2018/1941728. eCollection 2018.

DOI:10.1155/2018/1941728
PMID:30631602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6304578/
Abstract

Hepatocellular carcinoma is a major cause of cancer death worldwide, accounting for over half a million deaths per year. Its incidence varies with geographic locations and the type of etiologic factors. In Ethiopia, unidentified causes of liver disease are of sizeable proportion. Recent studies have shown an association of H. pylori infection with different spectrums of chronic liver disease. This study was conducted at St. Paul's Hospital Millennium Medical College in Ethiopia and assesses liver cancer and the association with H. pylori infection. A prospective case-control study conducted on patients with chronic liver disease presenting with a suspicious liver lesion and diagnosed to have HCC in the Gastrointestinal (GI) Clinic of St. Paul's Hospital MMC from Dec 30, 2016, to Nov 1, 2017 G.C. Descriptive surveys on clinical history and physical examination and laboratory profiles were obtained, and the clinical course of the patients including the type of treatment was followed prospectively. Control cases were taken from adult patients without evidence of liver disease in the internal medicine clinic coming for routine evaluation. After collection data were analyzed using SPSS version 23 and associations were assessed using chi-square test. Binary logistic regression was used to assess the association of HCC with different variables and H. pylori infection. All variables with p-value <0.05 were considered as statistically significant. One hundred twenty patients were analyzed with equal representation of cases and controls. The majority of patients with HCC were male with a mean age of 36 years. Older age adjusted Odds Ratio (AOR) (95%CI, p-value) 1.07(1.03-1.09, <0.001), viral hepatitis B (AOR) (95%CI, p-value) 6.19 (1.92-19.93, 0.002), and H. pylori infection (AOR) (95%CI, p-value) 5.22 (2.04-13.31, <0.001) were statistically significantly associated with HCC. H. pylori infection is associated with HCC in this case-control study. This study supports the emerging evidence of H. pylori association with other extra-gastric manifestations.

摘要

肝细胞癌是全球癌症死亡的主要原因,每年导致超过50万人死亡。其发病率因地理位置和病因类型而异。在埃塞俄比亚,不明原因的肝病占相当大的比例。最近的研究表明,幽门螺杆菌感染与不同类型的慢性肝病有关。本研究在埃塞俄比亚的圣保罗医院千禧医学院进行,评估肝癌及其与幽门螺杆菌感染的关联。对2016年12月30日至2017年11月1日在圣保罗医院MMC胃肠病诊所出现可疑肝脏病变并被诊断为肝癌的慢性肝病患者进行了一项前瞻性病例对照研究。收集了临床病史、体格检查和实验室检查结果的描述性调查资料,并对患者的临床病程(包括治疗类型)进行了前瞻性跟踪。对照病例来自内科诊所前来进行常规评估且无肝病证据的成年患者。收集数据后,使用SPSS 23版进行分析,并使用卡方检验评估相关性。采用二元逻辑回归分析肝癌与不同变量及幽门螺杆菌感染之间的关联。所有p值<0.05的变量均被视为具有统计学意义。共分析了120例患者,病例组和对照组人数相等。大多数肝癌患者为男性,平均年龄36岁。年龄较大(调整优势比[AOR](95%置信区间,p值)1.07[1.03 - 1.09,<0.001])、乙型病毒性肝炎(AOR)(95%置信区间,p值)6.19(1.92 - 19.93,0.002)和幽门螺杆菌感染(AOR)(95%置信区间,p值)5.22(2.04 - 13.31,<0.001)与肝癌在统计学上显著相关。在本病例对照研究中,幽门螺杆菌感染与肝癌有关。本研究支持了幽门螺杆菌与其他胃外表现相关的新证据。

相似文献

1
Helicobacter pylori Infection as a Risk Factor for Hepatocellular Carcinoma: A Case-Control Study in Ethiopia.幽门螺杆菌感染作为肝细胞癌的一个危险因素:埃塞俄比亚的一项病例对照研究。
Int J Hepatol. 2018 Dec 2;2018:1941728. doi: 10.1155/2018/1941728. eCollection 2018.
2
The association of infection with dyslipidaemia and other atherogenic factors in dyspeptic patients at St. Paul's Hospital Millennium Medical College.圣保罗医院千禧医学院消化不良患者感染与血脂异常及其他致动脉粥样硬化因素的关联
Heliyon. 2022 May 14;8(5):e09430. doi: 10.1016/j.heliyon.2022.e09430. eCollection 2022 May.
3
Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma.肝硬化和肝细胞癌患者的幽门螺杆菌血清流行率。
Cancer Detect Prev. 2003;27(6):494-7. doi: 10.1016/j.cdp.2003.07.004.
4
MAJOR RISK FACTORS, CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA; A RETROSPECTIVE STUDY AT TIKUR ANBASSA HOSPITAL, ADDIS ABABA UNIVERSITY, ADDIS ABABA, ETHIOPIA.肝细胞癌患者的主要危险因素、临床及实验室特征:埃塞俄比亚亚的斯亚贝巴大学提库尔安巴萨医院的一项回顾性研究
Ethiop Med J. 2015 Jul;53(3):127-32.
5
Helicobacter pylori infection and its association with anemia among adult dyspeptic patients attending Butajira Hospital, Ethiopia.埃塞俄比亚布塔吉拉医院成年消化不良患者的幽门螺杆菌感染及其与贫血的关联。
BMC Infect Dis. 2014 Dec 9;14:656. doi: 10.1186/s12879-014-0656-3.
6
The magnitude of suicidal ideation, attempts and associated factors of HIV positive youth attending ART follow ups at St. Paul's hospital Millennium Medical College and St. Peter's specialized hospital, Addis Ababa, Ethiopia, 2018.2018 年,在埃塞俄比亚亚的斯亚贝巴的圣保罗医院千年医药学院和圣彼得专门医院接受抗逆转录病毒治疗(ART)随访的 HIV 阳性青年的自杀意念、自杀企图及其相关因素的严重程度。
PLoS One. 2019 Nov 5;14(11):e0224371. doi: 10.1371/journal.pone.0224371. eCollection 2019.
7
Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.幽门螺杆菌感染与抗丙型肝炎病毒阳性肝硬化患者的细胞色素P-450肝脏代谢活性的更大损害有关。
Dig Dis Sci. 2003 Apr;48(4):802-8. doi: 10.1023/a:1022861414826.
8
Infection and Predictors Among Dyspeptic Adult Patients in Southwest Ethiopia: Cross-Sectional Study.埃塞俄比亚西南部消化不良成年患者的感染情况及预测因素:横断面研究
Res Rep Trop Med. 2020 Nov 19;11:141-147. doi: 10.2147/RRTM.S282557. eCollection 2020.
9
Prevalence of chronic kidney disease and associated factors among patients visiting renal unit of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia: A cross-sectional study design.埃塞俄比亚亚的斯亚贝巴圣保罗医院千禧医学院肾脏科就诊患者慢性肾脏病的患病率及相关因素:一项横断面研究设计
SAGE Open Med. 2022 Aug 9;10:20503121221116942. doi: 10.1177/20503121221116942. eCollection 2022.
10
Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.丙型肝炎病毒相关慢性肝炎、肝硬化和肝细胞癌患者的幽门螺杆菌感染
Dig Dis Sci. 2002 Jul;47(7):1638-43. doi: 10.1023/a:1015848009444.

引用本文的文献

1
Detection of H-Pylori in the Explanted Liver Tissue and the Enlarged Perihepatic Lymph Nodes of Cirrhotic Patients with Decompensated End-Stage Liver Disease Recruited for Liver Transplantation.对因终末期失代偿性肝病而接受肝移植的肝硬化患者的移植肝组织及肝周肿大淋巴结中幽门螺杆菌的检测
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):181-187. doi: 10.31557/APJCP.2025.26.1.181.
2
Effects and mechanisms of infection on the occurrence of extra-gastric tumors.感染对胃外肿瘤发生的影响及其机制。
World J Gastroenterol. 2024 Oct 7;30(37):4090-4103. doi: 10.3748/wjg.v30.i37.4090.
3
1,3,6-Trigalloylglucose: A Novel Potent Anti- Adhesion Agent Derived from Aqueous Extracts of Retz.1,3,6-三没食子酰葡萄糖:一种源自Retz.水提取物的新型强效抗黏附剂
Molecules. 2024 Mar 5;29(5):1161. doi: 10.3390/molecules29051161.
4
The role of infections in the causation of cancer in Kenya.肯尼亚感染在癌症病因学中的作用。
Cancer Causes Control. 2022 Dec;33(12):1391-1400. doi: 10.1007/s10552-022-01625-3. Epub 2022 Sep 10.
5
Lower Incidence of Hepatobiliary Cancer in Infected Persons: A Cohort Study of 53.633 Persons.感染者中肝胆癌发病率较低:一项对53633人的队列研究
J Clin Exp Hepatol. 2022 May-Jun;12(3):793-799. doi: 10.1016/j.jceh.2021.11.013. Epub 2021 Nov 26.
6
Coinfection of and Hepatitis C Virus in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.乙型肝炎病毒与丙型肝炎病毒合并感染在肝细胞癌发生发展中的作用:一项系统评价和Meta分析
J Clin Med Res. 2021 Dec;13(12):530-540. doi: 10.14740/jocmr4637. Epub 2021 Dec 28.
7
Cancer risk in chronic rhinosinusitis: a propensity score matched case-control cohort study.慢性鼻-鼻窦炎的癌症风险:一项倾向得分匹配的病例对照队列研究。
Am J Transl Res. 2019 Nov 15;11(11):7146-7156. eCollection 2019.

本文引用的文献

1
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.非洲肝细胞癌患者的特征、管理和结局:来自非洲肝癌联盟的多国观察性研究。
Lancet Gastroenterol Hepatol. 2017 Feb;2(2):103-111. doi: 10.1016/S2468-1253(16)30161-3. Epub 2016 Dec 3.
2
MAJOR RISK FACTORS, CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA; A RETROSPECTIVE STUDY AT TIKUR ANBASSA HOSPITAL, ADDIS ABABA UNIVERSITY, ADDIS ABABA, ETHIOPIA.肝细胞癌患者的主要危险因素、临床及实验室特征:埃塞俄比亚亚的斯亚贝巴大学提库尔安巴萨医院的一项回顾性研究
Ethiop Med J. 2015 Jul;53(3):127-32.
3
Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects.幽门螺杆菌:胃癌和胃外恶性肿瘤——临床方面。
Helicobacter. 2013 Sep;18 Suppl 1:39-43. doi: 10.1111/hel.12078.
4
Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties.67 个中国农村地区幽门螺杆菌感染与肝癌死亡率的关系。
Cancer Causes Control. 2013 Jul;24(7):1331-7. doi: 10.1007/s10552-013-0211-3. Epub 2013 Apr 7.
5
Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results.慢性幽门螺杆菌感染对阿尔茨海默病的影响:初步结果。
Neurobiol Aging. 2012 May;33(5):1009.e11-9. doi: 10.1016/j.neurobiolaging.2011.10.021. Epub 2011 Dec 1.
6
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.欧洲队列中肝细胞癌的危险因素和疾病负担:一项巢式病例对照研究。
J Natl Cancer Inst. 2011 Nov 16;103(22):1686-95. doi: 10.1093/jnci/djr395. Epub 2011 Oct 21.
7
Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp.肝细胞癌: Helicobacter 属的流行情况和分子发病机制
Future Microbiol. 2009 Dec;4(10):1283-301. doi: 10.2217/fmb.09.90.
8
DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma.原发性肝癌中幽门螺杆菌属及常见肠道细菌的DNA
Dig Liver Dis. 2008 Feb;40(2):126-31. doi: 10.1016/j.dld.2007.09.011. Epub 2007 Dec 20.
9
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.肝细胞癌:流行病学与分子致癌机制
Gastroenterology. 2007 Jun;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061.
10
Helicobacter pylori and extragastric diseases.幽门螺杆菌与胃外疾病
Best Pract Res Clin Gastroenterol. 2007;21(2):325-34. doi: 10.1016/j.bpg.2006.10.003.